Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| $16.7M | ﹤0.01% |
1,731,400
-66,200
| -4% | -$634K |
|
|
GRUB
1902
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $16.7M | ﹤0.01% |
112,400
-27,400
| -20% | -$4.05M |
|
1903
Invesco CurrencyShares Swiss Franc Trust
FXF
$414M
| $16.7M | ﹤0.01% |
161,817
+10,867
| +7% | +$1.1M |
|
1904
BridgeBio Pharma
BBIO
$15.7B
| $16.7M | ﹤0.01% |
234,283
+120,665
| +106% | +$5.82M |
|
1905
Madison Square Garden
MSGS
$9.48B
| $16.6M | ﹤0.01% |
90,436
-83,203
| -48% | -$13.7M |
|
1906
Sunstone Hotel Investors
SHO
$2.19B
| $16.6M | ﹤0.01% |
1,469,425
+1,431,749
| +3,800% | +$13.7M |
|
1907
PUT
KKR & Co
KKR
$91.1B
| $16.6M | ﹤0.01% |
411,000
-43,100
| -9% | -$1.63M |
|
1908
CALL
Lincoln National
LNC
$8.73B
| $16.6M | ﹤0.01% |
330,700
-6,800
| -2% | -$289K |
|
1909
Lockheed Martin
LMT
$134B
| $16.6M | ﹤0.01% |
46,777
+5,772
| +14% | +$2.12M |
|
1910
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $16.5M | ﹤0.01% |
498,842
+36,674
| +8% | +$1.18M |
|
1911
CALL
Devon Energy
DVN
$52.1B
| $16.5M | ﹤0.01% |
1,045,000
+580,200
| +125% | +$7.19M |
|
1912
CALL
JetBlue
JBLU
$2.28B
| $16.5M | ﹤0.01% |
1,134,600
+400,900
| +55% | +$5.5M |
|
1913
International Flavors & Fragrances
IFF
$20.2B
| $16.5M | ﹤0.01% |
151,531
-105,912
| -41% | -$11.9M |
|
|
1914
PUT
iShares Core S&P 500 ETF
IVV
$878B
| $16.5M | ﹤0.01% |
43,900
+1,700
| +4% | +$605K |
|
1915
PUT
Canadian Solar
CSIQ
$1.02B
| $16.5M | ﹤0.01% |
321,600
+94,900
| +42% | +$3.89M |
|
1916
PUT
ARK Web x.0 ETF
ARKW
$1.63B
| $16.5M | ﹤0.01% |
112,500
+107,200
| +2,023% | +$13.7M |
|
|
1917
PUT
JetBlue
JBLU
$2.28B
| $16.5M | ﹤0.01% |
1,131,400
+635,300
| +128% | +$8.72M |
|
|
BAND
1918
Bandwidth Inc
BAND
$1.26B
| $16.4M | ﹤0.01% |
106,658
+90,708
| +569% | +$15M |
|
1919
CALL
MarketAxess Holdings
MKTX
$5.71B
| $16.4M | ﹤0.01% |
28,700
-4,600
| -14% | -$2.51M |
|
1920
Ericsson
ERIC
$32.2B
| $16.4M | ﹤0.01% |
1,368,852
+1,124,560
| +460% | +$13.2M |
|
1921
iShares Russell 1000 Growth ETF
IWF
$121B
| $16.4M | ﹤0.01% |
271,228
+255,400
| +1,614% | +$14.5M |
|
|
KSU
1922
CALL
DELISTED
Kansas City Southern
KSU
| $16.4M | ﹤0.01% |
80,100
-136,500
| -63% | -$25.6M |
|
|
SGEN
1923
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $16.3M | ﹤0.01% |
93,300
+15,100
| +19% | +$2.82M |
|
1924
CALL
Emerson Electric
EMR
$83.9B
| $16.3M | ﹤0.01% |
203,300
-180,500
| -47% | -$13.4M |
|
|
GBT
1925
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $16.3M | ﹤0.01% |
377,245
-298,927
| -44% | -$14.7M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.